Tumor markers usually are detected with the laboratory methods like ELISA, PCR or CT. But these tests must be performed in a hospital lab, or in a well equipped diagnostic lab, which is both slow and costly. Our new method can be performed virtually anywhere, such as at home, doctor's office, or as a rapid test with immediate results in any diagnostics center, or hospital. The test device can be stored at room temperature for 18-24 months and used as needed. In addition to our lateral flow test patent, we have filed US and PCT patents for the meter which will allow for results to be obtained immediately at Point of Care (Doctor's office or at home). These patents were published in March 2022.